CompoAtlas

Qian Bai Bi Yan Pian (Sugar Coated)

Texto original en francés.

Producto de salud natural autorizado en Canadá

Otros nombres
Qian Bai Bi Yan Pian, Qian Bai Bi Yan Tablets
Titular
Wing Quon Enterprises Ltd.
NPN o DIN-HM
80081083
Estado
Licencia activa
Fecha de licencia
6 de noviembre de 2017
Fecha de revisión
No indicada
Forma
Comprimé
Vía de administración
Orale
Tipo de solicitud
Traditionnelle

Si este producto se vendiera en Francia

Solo se calcula una cantidad diaria para una posología oral explícita para adultos, expresada por día y en una unidad sólida correspondiente a la forma del producto. No se extrapolan las unidades ambiguas, los líquidos, los polvos ni las dosis pediátricas. Una cantidad no calculada no se compara con los límites de dosis. Este análisis no constituye una autorización de venta en Francia ni una evaluación de seguridad o eficacia.

Composición

Ingrediente medicinal y fuentePor unidad posológica, según la fuenteMáximo diario, adulto
Ligusticum sinense cv. chuanxiong

Fuente : Rhizome

8 mgNo calculada
Senna obtusifolia

Fuente : Graine(s)

Extracto : Matériel brut sec

Relación de extracción : 8:1

Equivalente de planta seca : 242 mg

30,25 mgNo calculada

Ingredientes no medicinales

Sucrose

Dosis recomendadas en Canadá

PoblaciónEdadCantidad por tomaFrecuencia
AdultesNon préciséeminimum : 3 Comprimé ; maximum : 4 Comprimé3 jours

Usos autorizados en Canadá

Traditional Chinese Medicine to clear heat and toxicity, expel wind, disseminate lung-qi and free the orifices; used for stuffy nose, itching nose, yellow-thick nasal discharge or hyposmia due to invasion of the lung by wind-heat, which transforms into fire, hampering normal flow of qi; acute and chronic rhinitis, acute and chronic sinusitis with above symptoms.

Texto original en inglés.

Un uso autorizado en Canadá no es una declaración de propiedades saludables autorizada en la Unión Europea. Consulte el registro de declaraciones de propiedades saludables.

Advertencias en Canadá

Cautions and Warnings : If you are taking prescription medications, consult a health care practitioner prior to use. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for allergy symptoms. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for asthma. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for cough/cold. Consult a health care practitioner prior to use if you are taking medication and/or natural health products for weight control. Consult a healthcare practitioner prior to use if you are taking other products which contain caffeine. Consult a healthcare practitioner prior to use if you are taking other products which contain ephedrine. Consult a healthcare practitioner prior to use if you are taking other products which contain phenylpropanolamine. Consult a healthcare practitioner prior to use if you are taking other products which contain pseudoephedrine. Consult a health care practitioner prior to use if you have cardiovascular disease. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you have difficulty in urination due to prostate enlargement. Consult a health care practitioner prior to use if you have glaucoma. Consult a health care practitioner prior to use if you have pre-existing psychiatric conditions. Consult a health care practitioner prior to use if you have seizure disorders. Consult a health care practitioner prior to use if you have thyroid problems. Consult a health care practitioner prior to use if you have liver disorder. If yellowing of the skin or whites of the eyes, dark urine, nausea, vomiting, unusual tiredness, weakness, stomach or abdominal pain, and /or loss of appetite occurs, discontinue use and consult a health care practitioner, as these may be symptoms of liver disease. Consult a health care practitioner prior to use if you are taking thiazide diuretics, corticosteroids, licorice root or other medications or health products which may aggravate electrolyte imbalance. Consult a health care practitioner prior to use if you have a kidney disorder or are taking cardiac medications such as cardiac glycosides or antiarrhythmic medications. Consult a health care practitioner prior to use if you have faecal impaction or symptoms such as abdominal pain, nausea, vomiting or fever.

Texto original en inglés.

Contra-Indications : Do not use if you are taking; or have taken in the past two weeks monoamine oxidase (MAO) inhibitors. Do not use if you are pregnant or breastfeeding. Do not use if you have abnormal constrictions of the gastrointestinal tract, potential or existing intestinal blockage, atonic bowel, appendicitis, inflammatory colon disease such as Crohn's disease or ulcerative colitis, abdominal pain of unknown origin, undiagnosed rectal bleeding, severe dehydration with depleted water or electrolytes or diarrhoea.

Texto original en inglés.

Known Adverse Reactions : Insomnia has been known to occur; in which case; discontinue use. Irritability; dizziness and/or tremor have been known to occur; in which case; discontinue use. Nausea and/or loss of appetite have been known to occur; in which case; discontinue use. Rapid heartbeat has been known to occur; in which case; discontinue use. Restlessness has been known to occur; in which case; discontinue use. Severe headache has been known to occur; in which case; discontinue use. Shortness of breath; and/or disturbance of urination have been known to occur; in which case; discontinue use. Laxative effect may occur. Hypersensitivity is known to occur, in which case, discontinue use.

Texto original en inglés.

Fuente

Ficha oficial de Health Canada, licencia 80081083

Base de datos de productos de salud natural autorizados (BDPSNH), Health Canada: productos autorizados, ingredientes, dosis, usos y advertencias, consultado el 27 de octubre de 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Texto original en inglés.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Texto original en francés.

La fórmula vendida en Europa con el mismo nombre puede ser diferente. Esta información no sustituye el consejo de un médico o farmacéutico.

Se desconoce la fecha de la prueba de esta lista de ingredientes.

¿Ha cambiado el producto? Fotografíe el envase.

¿Alguna información inexacta o más reciente sobre este producto, sea usted lector o marca? Escriba a contact@compoatlas.com: cada corrección se publica en el registro de correcciones.

Intro para analizar, Mayús+Intro para una nueva línea